Glad that has been cleared up because I did think that the trial for efficacy was with SOC and thought that the dosage would also have to be for the same ethical reasons. The beauty of the standalone treatment as small as it is to minimise risk is that there could be good early indication of efficacy and that is what Team IMU and holders really want to see. Fingers crossed firstly for patients and secondly for the rest of us.
Media Thread, page-255
-
- There are more pages in this discussion • 15,575 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.9¢ | 4.8¢ | $179.8K | 3.692M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 8124186 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3070575 | 9 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |